AX-2025-019000 · Hexarelin · ASY lot ASY-{CAT}-1786

Section 1

Results

Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

Parameter	Method	Result	Unit	Index spec
Purity	RP-HPLC, 30 min gradient, 214 nm	99.56	% area	≥ 99.0	PASS
Total impurities	RP-HPLC, sum of reported peaks	0.44	% area	≤ 1.0	PASS
Largest single impurity	RP-HPLC — oxidised Trp (+16 Da)	0.18	% area	≤ 1.00	PASS
Identity	not ordered on this submission	not determined	—	required for VERIFIED status	NOT TESTED
Total peptide content	by difference from the gravimetric mass balance	90.26	%w/w	—	NOT TESTED
Target-compound content	total peptide content × purity	89.86	%w/w	—	NOT TESTED
Gross fill (as weighed)	five-place balance, under nitrogen	10.08	mg	10 mg declared	NOT TESTED
Recovered target peptide	gross fill × target content	9.058	mg	10 mg claim	NOT TESTED
Recovery against label claim	recovered ÷ claim	90.6	%	90.0 – 110.0	PASS
Water content	Karl Fischer, coulometric, duplicate	3.93	%	≤ 9.0	PASS
Counter-ion (acetate)	anion-exchange ion chromatography	5.14	%	≤ 12.0	PASS
Residual solvent + inorganic residue	estimated — see /methods/residual-solvents-q3c/	0.67	%	—	NOT TESTED
Endotoxin	kinetic chromogenic LAL	2.72	EU/mg	≤ 5.0	PASS
Sterility	not ordered on this submission	not determined	—	no growth	NOT TESTED
Appearance	visual, diffuse light, black and white background	White cake, partial shrinkage from vial wall	—	white to off-white intact cake	FAIL
Reconstitution clarity	reconstituted per submitter procedure	Clear after 90 s gentle swirling, no particulates	—	clear, no visible particulates	PASS
pH (reconstituted, 1 mg/mL)	potentiometric, two-point calibration	4.64	—	2.5 – 8.0	PASS
Retention time (observed)	RP-HPLC, 30 min gradient	8.96	min	8.92 ± 0.25 (normalised)	PASS
Peak asymmetry (10 % height)	Ph. Eur. 2.2.46	1.01	—	0.80 – 1.50	PASS
Plate count, main peak	N = 5.54 (t/w½)²	65,472	—	≥ 20,000	PASS
Resolution to nearest impurity	vs C-terminal free acid (+1 Da)	1.11	—	no index criterion	REPORTED

Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

Figure 1. RP-HPLC trace, 30 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 65,472, and skew follows the reported asymmetry factor of 1.01. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.18 % impurity against a 99.56 % main peak is a line two pixels tall; the main peak runs off-scale there by design.

#	Peak	RT	Area (µV·s)	% area	Δ mass (Da)
1	Hexarelin — main peak	8.96	4,838,925	99.56	—
2	oxidised Trp (+16 Da)	8.62	8,749	0.18	+15.995
3	des-methyl hexarelin (GHRP-6, −14 Da)	8.48	5,346	0.11	-14.016
4	des-Lys (−128 Da)	8.74	4,374	0.09	-128.095
5	C-terminal free acid (+1 Da)	9.12	2,916	0.06	+0.984
Closure check — purity + Σ impurities				100.00	CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

Component	Determination	%w/w of cake
Water	Karl Fischer	3.93
Counter-ion (acetate)	ion chromatography	5.14
Residual solvent + inorganic residue	estimated	0.67
Total peptide content	by difference	90.26
Total		100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

Figure	Supplier COA	This report	Index note
Purity (% area)	99.90	99.56	divergence +0.08 pp vs batch median
Total impurities (% area)	not stated	0.44
Largest single impurity (% area)	not stated	0.18
Water (%)	3.1	3.93
Counter-ion (%)	5.1	5.14
Peptide content (%w/w)	91.2	90.26
Endotoxin (EU/mg)	not stated	2.72
Method stated on certificate	YES	—	column, gradient and wavelength given

Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance: Laboratory-retained
Evidentiary weight: Provenance documented, selection uncontrolled.
Chain of custody: Laboratory retained sample (−20 °C, 21 d since original receipt) → re-assay.
Assay date: 17 Feb 2025
Submitted to the index: 10 Mar 2025
Laboratory: Janoshik Analytical, Ostrava, Czechia
Method basis: 30 min gradient · high-resolution MS
Verification status: PURITY ONLY

What this report does not establish

That the compound is the compound named. No identity confirmation was ordered on this submission. A purity figure describes chromatographic homogeneity of whatever eluted; it does not name it.
That the material is sterile. Sterility was not tested.
That any other vial in the same lot has the same composition. One vial was tested. Within-lot vial-to-vial variation in this index has a median of 0.28 pp and a 90th percentile of 0.74 pp.
That any other lot from the same supplier has the same composition. Batch-to-batch variation is larger than within-batch variation for every supplier here.
That the material is suitable for administration to a human or an animal. These are research compounds. No result on this site is a safety assessment and the index takes no position on use.
That the material was manufactured by the supplier that sold it. Contract synthesis is normal in this market and twenty-nine batches in the index fingerprint to a bulk from a different company than the one named on the label.

Section 6

Annotations 2

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

retest_date10 Mar 2025

A retest date on the certificate would tell you what the supplier is actually asserting about stability. Purity at 99.56 % on assay day is a starting condition, not a shelf life.

plate_count10 Mar 2025

Where the plate count is low the resolution figure is low for a reason that has nothing to do with the impurity profile. Read the two together or read neither.

Section 7

Related records

Same batch — lot ASY-{CAT}-1786 n=11

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2025-018995	ASY-{CAT}-1786	Janoshik	2025-Q1	99.80	4.22	—	Buyer-sourced	0	PASS
AX-2025-018996	ASY-{CAT}-1786	PeptideMeter	2025-Q1	99.39	4.13	—	Buyer-sourced	0	PASS
AX-2025-018997	ASY-{CAT}-1786	Nordanalyt	2025-Q1	99.61	3.84	107.2	Buyer-sourced	0	PASS
AX-2025-018998	ASY-{CAT}-1786	PeptideMeter	2025-Q1	99.92	4.90	—	Buyer-sourced	0	PASS
AX-2025-018999	ASY-{CAT}-1786	Janoshik	2025-Q1	99.75	4.22	93.1	Buyer-sourced	0	PASS
AX-2025-019001	ASY-{CAT}-1786	Nordanalyt	2025-Q1	99.93	4.39	—	Buyer-sourced	1	MARGINAL
AX-2025-019002	ASY-{CAT}-1786	Janoshik	2025-Q1	99.86	4.24	99.8	Buyer-sourced	0	PASS
AX-2025-019003	ASY-{CAT}-1786	Janoshik	2025-Q1	99.93	4.89	89.7	Buyer-sourced	1	MARGINAL
AX-2025-019004	ASY-{CAT}-1786	Medutest	2025-Q1	99.82	3.83	106.4	Buyer-sourced	0	PASS
AX-2025-019005	ASY-{CAT}-1786	Janoshik	2025-Q1	99.91	4.76	103.5	Buyer-sourced	0	PASS

Batch rollup and reproducibility assessment →

Cross-sections

Other recent Hexarelin records in the index.
Report	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Result
AX-2026-042177	JEEP	JEEP-2608-Y9547	Janoshik	2026-Q3	99.90	3.42	—	Buyer-sourced	PASS
AX-2026-042178	JEEP	JEEP-2608-Y9547	VendorInvestigate	2026-Q3	99.68	4.03	—	Buyer-sourced	PASS
AX-2026-043097	KP	KP-2604-X5990	Medutest	2026-Q2	99.55	2.60	—	Laboratory-retained	PASS
AX-2026-043253	CPC	CPC-2511-F9455	Janoshik	2026-Q2	98.53	6.11	—	Buyer-sourced	FAIL
AX-2026-043098	KP	KP-2604-X5990	PeptideMeter	2026-Q2	98.66	3.14	—	Buyer-sourced	FAIL
AX-2026-042366	Homopeptide	HOMO-2602-R3080	Janoshik	2026-Q2	99.55	4.14	—	Buyer-sourced	PASS
AX-2026-042365	Homopeptide	HOMO-2602-R3080	PeptideMeter	2026-Q2	99.66	4.44	94.8	Buyer-sourced	PASS
AX-2026-043100	KP	KP-2604-X5990	Janoshik	2026-Q2	98.82	3.57	92.0	Buyer-sourced	FAIL

Other recent ASY records in the index.
Report	Compound	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041776	TB-500	ASY-{CAT}-2167	Janoshik	2026-Q3	99.92	4.61	98.2	Buyer-sourced	0	PASS
AX-2026-041777	TB-500	ASY-{CAT}-2167	PeptideMeter	2026-Q3	99.78	4.09	92.8	Buyer-sourced	0	PASS
AX-2026-041786	Retatrutide	ASY-{CAT}-2288	VendorInvestigate	2026-Q3	98.78	6.59	—	Buyer-sourced	0	PASS
AX-2026-041782	TB-500	ASY-{CAT}-2167	Nordanalyt	2026-Q3	99.93	3.94	—	Buyer-sourced	0	PASS
AX-2026-041793	Retatrutide	ASY-{CAT}-2288	Nordanalyt	2026-Q3	98.34	6.16	104.8	Buyer-sourced	0	PASS
AX-2026-041784	Retatrutide	ASY-{CAT}-2288	PeptideMeter	2026-Q3	98.15	6.26	91.9	Buyer-sourced	0	PASS
AX-2026-041774	TB-500	ASY-{CAT}-2167	PeptideMeter	2026-Q3	99.93	4.41	96.2	Buyer-sourced	0	PASS
AX-2026-041780	TB-500	ASY-{CAT}-2167	Janoshik	2026-Q3	99.93	3.48	102.5	Buyer-sourced	1	FAIL